It will be interesting to see what COVISTIX revenue will be revealed from Q1 2022 report. I expect it to ramp up quarter over quarter for the rest of the year. And I would expect US and Canadian approvals very soon. But what I am most interested in is the VIREX technology.
Near PCR quality, 5 minute tests at about 10% of the cost of other technologies would be a real winner. And it would have application to many viruses and many cancers. Just think if there are such tests available for lung, pancreatic, ovarian and brain cancers that are frequently discovered too late, whereas if they were detected early, could be cured! I know one of the consulting scientists worked for the Livermore Laboratory and BARDA. It is cutting edge technology!
News 
Market Data 
Discover 
